BIOTECH (165) Themis Bioscience GmbH: Merck’s wholly-owned subsidiary – Recombinant Measles Vector Vaccine Platform April 1, 2024April 1, 2024
BIOTECH (164) Omega Therapeutics: Insulated Genomic Domain (IGD) Platform – Controllable Epigenomic Programming Platform April 1, 2024April 1, 2024
BIOTECH (162) Idorsia Pharmaceuticals: Johnson & Johnson/Actelion Merger Spinoff – first Endothelin Receptor Antagonist Aprocitentan FDA Approval March 31, 2024March 31, 2024
PRODUCTIVE LONGEVITY (6) Super Agers Study – 신경과 정지향 교수 강의 & AARP 7 Secrets March 31, 2024March 31, 2024